back to team members

Martin Madaus, PhD

Chief Operations Officer, Sherlock Biosciences, Inc.


Martin brings more than 20 years of experience in the diagnostics and life science industries. He currently serves as Chief Operations Officer at Sherlock Biosciences, Inc. Prior to that he served as Chairman and CEO of Ortho Clinical Diagnostics, Inc. Previously, he served as President, Chairman and CEO of Millipore Corporation, recently acquired by Merck KGaA. Before joining Millipore, Dr. Madaus was President, CEO and head of North American Operations for Roche Diagnostics Corporation. Prior to this he served as Vice President of Business Development for Roche Molecular Diagnostics and General Manager of Boehringer Mannheim Canada. He also held a number of senior-level sales, marketing and product management positions with Boehringer Mannheim Corporation in both Germany and the US. Dr. Madaus also serves on the boards of the following private biotechnology companies: Ultivue, Inc., Emulate, Inc., and Candela Medical. He holds a Doctor of Veterinary Medicine from the University of Munich, Germany and a Ph.D. in Veterinary Medicine from the Veterinary School of Hanover, Germany.